Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
22.75
+1.41 (6.58%)
At close: Oct 15, 2026, 4:00 PM EDT
22.88
+0.13 (0.59%)
After-hours: Oct 15, 2026, 7:36 PM EDT
Fortrea Holdings Employees
Fortrea Holdings had 14,000 employees as of June 30, 2026. The number of employees decreased by 500 or -3.45% compared to the same quarter last year. That makes Fortrea Holdings the 2,535th largest employer in the world and 605th in the United States.
Employees
14,000
Change
-500
Growth
-3.45%
Revenue / Employee
$191,179
Profits / Employee
-$6,086
Market Cap
2.16B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 14,000 | -500 | -3.45% | 14,000 | 0 |
| Mar 31, 2026 | 14,000 | -1,000 | -6.67% | 14,000 | 0 |
| Dec 31, 2025 | 14,300 | -1,820 | -11.29% | 13,871 | 429 |
| Sep 30, 2025 | 14,500 | -1,000 | -6.45% | 14,500 | 0 |
| Jun 30, 2025 | 14,500 | -1,500 | -9.38% | 14,500 | 0 |
| Mar 31, 2025 | 15,000 | -1,000 | -6.25% | 15,000 | 0 |
| Dec 31, 2024 | 16,120 | -1,880 | -10.44% | 15,500 | 620 |
| Sep 30, 2024 | 15,500 | -3,500 | -18.42% | 15,500 | 0 |
| Jun 30, 2024 | 16,000 | -3,000 | -15.79% | 16,000 | 0 |
| Mar 31, 2024 | 16,000 | -2,000 | -11.11% | 16,000 | 0 |
| Dec 31, 2023 | 18,000 | 0 | - | 17,460 | 540 |
| Sep 30, 2023 | 19,000 | 1,000 | 5.56% | 19,000 | 0 |
| Jun 30, 2023 | 19,000 | - | - | 19,000 | 0 |
| Mar 31, 2023 | 18,000 | - | - | 17,370 | 630 |
| Dec 31, 2022 | 18,000 | - | - | 17,370 | 630 |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Recursion Pharmaceuticals | 600 |
| Vericel | 398 |
| Vera Therapeutics | 361 |
| Harmony Biosciences Holdings | 293 |
| Viridian Therapeutics | 252 |
| Celldex Therapeutics | 198 |
| Disc Medicine | 165 |
FTRE News
- 18 hours ago - Deutsche upgrades Fortrea to Buy on ‘fundamental inflection point’ - TheFly
- 19 hours ago - Fortrea upgraded to Buy from Hold at Deutsche Bank - TheFly
- 6 days ago - Fortrea price target raised to $15.50 from $13 at BofA - TheFly
- 9 days ago - Fortrea upgraded to Overweight from Equal Weight at Barclays - TheFly
- 10 days ago - Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference Call - GlobeNewsWire
- 15 days ago - Fortrea initiated with a Neutral at UBS - TheFly
- 4 weeks ago - Fortrea Holdings Transcript: 2026 Global Healthcare Conference - Transcripts
- 5 weeks ago - Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire